Formal synthesis of Leucascandrolide A

Angewandte Chemie - International Edition

Volumn 42, Issue 33, 2003, Pages 3934-3938

  Williams, David R ^a   Plummer, Scott V ^a   Patnaik, Samarjit ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Allylation; Antitumor agents; Asymmetric synthesis; Macrolide; Natural products

Indexed keywords

HYDRIDES; REDUCTION; SYNTHESIS (CHEMICAL);

ALLYLATION REACTIONS;

KETONES;

ALLYL COMPOUND; ANTINEOPLASTIC AGENT; LACTONE; LEUCASCANDROLIDE A; MACROLIDE; NATURAL PRODUCT; SESQUITERPENE; UNCLASSIFIED DRUG;

ALLYLATION; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; ASYMMETRIC SYNTHESIS; CANCER CELL CULTURE; CANDIDA ALBICANS; CHEMISTRY; DRUG CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LEUKEMIA CELL LINE; MARINE ENVIRONMENT; NEW CALEDONIA; NONHUMAN; SPONGE (PORIFERA); STEREOCHEMISTRY; SYNTHESIS;

ALLYL COMPOUNDS; ANTINEOPLASTIC AGENTS; MACROLIDES; SESQUITERPENES;

EID: 0042819672     PISSN: 14337851     EISSN: None     Source Type: Journal    
DOI: 10.1002/anie.200351817     Document Type: Article

References (39)

1. M. D'Ambrosio, A. Guerriero, C. Debitus, F. Pietra, Helv. Chim. Acta 1996, 79, 51.
2. M. D'Ambrosio, M. Tatò, G. Pocsfalvi, C. Debitus, F. Pietra, Helv. Chim. Acta 1999, 82, 347.
3. a) M. T. Crimmins, C. A. Carroll, B. W. King, Org. Lett. 2000, 2, 597;
4. b) S. A. Kozmin, Org. Lett. 2001, 3, 755;
5. c) P. Wipf, T. H. Graham, J. Org. Chem. 2001, 66, 3242;
6. d) L. A. Dakin, N. F. Langille, J. S. Panek, J. Org. Chem. 2002, 67, 6812.
7. a) K. R. Hornberger, C. L. Hamblett, J. L. Leighton, J. Am. Chem. Soc. 2000, 122, 12894;
8. b) A. Fettes, E. M. Carreira, Angew. Chem. 2002, 114, 4272; Angew. Chem. Int. Ed. 2002, 41, 4098;
9. b) A. Fettes, E. M. Carreira, Angew. Chem. 2002, 114, 4272; Angew. Chem. Int. Ed. 2002, 41, 4098;
10. c) Y. Wang, J. Janjic, S. A. Kozmin, J. Am. Chem. Soc. 2002, 124, 13670;
11. d) I. Paterson, M. Tudge, Angew. Chem. 2003, 115, 357; Angew. Chem. Int. Ed. 2003, 42, 343.
12. d) I. Paterson, M. Tudge, Angew. Chem. 2003, 115, 357; Angew. Chem. Int. Ed. 2003, 42, 343.
13. a) D. J. Kopecky, S. D. Rychnovsky, J. Am. Chem. Soc. 2001, 123, 8420;
14. b) P. Wipf, J. T. Reeves, Chem. Commun. 2002, 2066.
15. The synthesis of the epoxide 5 proceeds through the alkylation of 2-lithio-1,3-dithiane with (R)-epichlorohydrin (97% ee, Aldrich): a) M. Braun, D. Seebach, Chem. Ber. 1976, 109, 669; b) D. Seebach, I. Willert, A. Beck, B. T. Groebel, Helv. Chim. Acta 1978, 61, 2510.
16. The synthesis of the epoxide 5 proceeds through the alkylation of 2-lithio-1,3-dithiane with (R)-epichlorohydrin (97% ee, Aldrich): a) M. Braun, D. Seebach, Chem. Ber. 1976, 109, 669; b) D. Seebach, I. Willert, A. Beck, B. T. Groebel, Helv. Chim. Acta 1978, 61, 2510.
17. a) H. Nishiyama, H. Yokoyama, S. Narimatsu, K. Itoh, Tetrahedron Lett. 1982, 23, 1267;
18. b) B. M. Trost, T. A. Grese, D. M. T. Chan, J. Am. Chem. Soc. 1991, 113, 7350.
19. E. J. Corey, C. M. Yu, S. S. Kim, J. Am. Chem. Soc. 1989, 111, 5495.
20. The synthesis of the aldehyde 8 proceeds by the mono-pmethoxybenzylation of 1,3-propanediol followed by Swern oxidation: A. J. Mancuso, D. Swern, Synthesis 1981, 165.
21. For the development of this asymmetric-allylation methodology, see: D. R. Williams, D. A. Brooks, K. G. Meyer, M. P. Clark, Tetrahedron Lett. 1998, 39, 7251.
22. S. Takano, S. Hatakeyama, K. Ogasawara, J. Chem. Soc. Chem. Commun. 1977, 68.
23. The bromide 10 is available from the corresponding homoallylic alcohol by tosylation (TsCl, D MAP, pyridine; 98%), followed by exchange with lithium bromide (DME 50°C; 65%). For the synthesis of the starting homoallylic alcohol, see: J. D. White, G. N. Reddy, G. O. Spessard, J. Am. Chem. Soc. 1988, 110, 1624.
24. The epoxide 11 is available from D-malic acid in four steps. (equation presented)
25. D. Comins, A. Dehghani, Tetrahedron Lett. 1992, 33, 6299.
26. 2] to be an efficient catalyst for the conversion of the enol triflate into the allyl silane 14.
27. A complete study of matched and mismatched elements of stereochemistry will be detailed in further reports devoted to the asymmetric-allylation process.
28. a) S. Terashima, N. Tanno, K. Koga, J. Chem. Soc. Chem. Commun. 1980, 1026;
29. b) S. Terashima, N. Tanno, K. Koga, Chem. Lett. 1980, 981;
30. c) N. Tanno, S. Terashima, Chem. Pharm. Bull. 1983, 31, 837.
31. D. R. Williams, D. A. Brooks, M. A. Berliner, J. Am. Chem. Soc. 1999, 121, 4924.
32. D. B. Dess, J. C. Martin, J. Am. Chem. Soc. 1991, 113, 7277.
33. Either of the diastereomeric alcohols (R or S at C17) could potentially be a valuable intermediate toward lactone 2, depending on the strategy chosen: macrocyclization with retention of configuration at C17 (Yamaguchi protocol) or Mitsunobu macrocyclization with inversion of configuration at C17. For example, compare the reports of references [4a] and [5b].
34. a) P. Wipf, W. Xu, Tetrahedron Lett. 1994, 35, 5197;
35. b) P. Wipf, S. Ribe, J. Org. Chem. 1998, 63, 6454.
36. a) E. J. Corey, R. K. Bakshi, S. Shibata, C. P. Chen, V. K. Singh, J. Am. Chem. Soc. 1987, 109, 7925;
37. b) D. J. Mathre, T. K. Jones, L. C. Xavier, T. J. Blacklock, R. A. Reamer, J. J. Mohan, E. T. T. Jones, K. Hoogsteen, M. W. Baum, E. J. J. Grabowski, J. Org. Chem. 1991, 56, 751.
38. a) J. Inanaga, K. Hirata, H. Saeki, T. Katsuki, M. Yamaguchi, Bull. Chem. Soc. Jpn. 1979, 52, 1989;
39. b) M. Hikota, Y. Sakurai, K. Horita, O. Yonemitsu, Tetrahedron Lett. 1990, 31, 6367.